K2VC is an early-stage venture capital firm that primarily focuses on angel and early-stage investments in technology, business model innovation, and consumer lifestyle companies. The firm's strategy involves backing founders in sectors such as deep tech, clean tech, robotics, software, and healthcare, aiming to drive industrial upgrades and consumer lifestyle revolutions.
33% of their portfolio is in Biotech & Life Sciences. Their most common stage is series-a (50% of deals). Average disclosed round size is $43.0M (across 5 rounds with reported amounts).
Portfolio
6
Fund Size
$1B
Top Stage
Series A
Last 12 Mo
0
Portfolio Breakdown
Stage Distribution
Sector Distribution
Investment Activity
DealsAvg Round Size
Portfolio
6 investments
| Company | Round | Amount | Date |
|---|---|---|---|
 Cornerstone Robotics | Series C | $70M | Jan 2025 |
 ProfoundBio | Series A | $70M | Jun 2022 |
 SUNRATE | Series C | — | Jan 2022 |
| ProfoundBio | Series A | $55M | Jul 2021 |
 Yamibuy | Series A | $10M | Jul 2017 |
 Tripalink | Series B | $10M | — |
Top Co-Investors
Lilly Asia Ventures2 shared
LYFE Capital2 shared
Sequoia China2 shared
Oriza2 shared
Gaorong Capital1 shared
SoftBank Ventures Asia1 shared
JAFCO Asia1 shared
China Growth Capital1 shared
EQT Ventures1 shared
Alpha JWC1 shared
GGV Capital1 shared
Last updated: 8 March 2026